[
  {
    "date": "2022-12-30",
    "symbol": "CELUW",
    "period": "FY",
    "entityregistrantname": "Celularity Inc.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1752828,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated filer",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38914",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "83-1702591",
    "entityaddressaddressline1": "170 Park Ave",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": "(908)",
    "localphonenumber": "768-2170",
    "security12btitle": "Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share",
    "tradingsymbol": "CELUW",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Morristown, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 13966000,
    "accountsandotherreceivablesnetcurrent": 4452000,
    "promissorynotesreceivable": 2514000,
    "inventorynet": 5308000,
    "prepaidexpenseandotherassetscurrent": 7262000,
    "assetscurrent": 33502000,
    "propertyplantandequipmentnet": 75655000,
    "goodwill": 7347000,
    "intangibleassetsnetexcludinggoodwill": 120994000,
    "operatingleaserightofuseasset": 13060000,
    "restrictedcashnoncurrent": 14722000,
    "inventorynoncurrent": 22949000,
    "otherassetsnoncurrent": 376000,
    "assets": 401066000,
    "accountspayablecurrent": 5810000,
    "accruedliabilitiesandotherliabilities": 16402000,
    "shorttermborrowings": 37603000,
    "contractwithcustomerliabilitycurrent": 2273000,
    "liabilitiescurrent": 62088000,
    "contractwithcustomerliabilitynoncurrent": 2219000,
    "businesscombinationcontingentconsiderationliability": 105945000,
    "operatingleaseliabilitynoncurrent": 27985000,
    "warrantliability": 3598000,
    "deferredincometaxliabilitiesnet": 9000,
    "otherliabilitiesnoncurrent": 321000,
    "liabilities": 59202000,
    "commonstockvalue": 15000,
    "additionalpaidincapital": 844373000,
    "accumulatedothercomprehensiveincomelossnetoftax": 9000,
    "retainedearningsaccumulateddeficit": -645496000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 198901000,
    "liabilitiesandstockholdersequity": 401066000,
    "allowancefordoubtfulaccountsreceivablecurrent": 1789000,
    "shorttermdebtfairvalue": 37603000,
    "debtdefaultshorttermdebtamount": 37000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 12463000,
    "costofrevenue": 13776000,
    "researchanddevelopmentexpense": 78363000,
    "sellinggeneralandadministrativeexpense": 66021000,
    "changeinfairvalueofcontingentconsiderationliability": -126277000,
    "goodwillimpairmentloss": 3610000,
    "amortizationofintangibleassets": 2193000,
    "operatingincomecostsandexpenses": 43575000,
    "operatingincomeloss": -25600000,
    "othernonoperatingincome": 365000,
    "fairvalueadjustmentofwarrants": 23766000,
    "changeinfairvalueofdebt": 2522000,
    "othernonoperatingincomeexpenses": -147000,
    "nonoperatingincomeexpense": 39805000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 14205000,
    "incometaxexpensebenefit": 13000,
    "netincomeloss": 14192000,
    "othercomprehensiveincomelossfinancialliabilityfairvalueoptionaftertaxandreclassificationadjustmentattributabletoparent": 9000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 9000,
    "comprehensiveincomenetoftax": 14201000,
    "earningspersharebasic": 0.1,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "earningspersharediluted": 0.09,
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "stockholdersequity": 198901000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluereclassificationofpreviouslyexercisedstockoptions": 441000,
    "stockissuedduringperiodsharesreclassificationofpreviouslyexercisedstockoptions": 131253,
    "stockissuedduringperiodvaluestockoptionsexercised": 948000,
    "stockissuedduringperiodsharesstockoptionsexercised": "null",
    "stockrepurchasedandretiredduringperiodvalue": -86000,
    "stockrepurchasedandretiredduringperiodshares": -10499,
    "stockissuedduringperiodvaluewarrantsexercised": 46491000,
    "stockissuedduringperiodshareswarrantsexercised": "null",
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 4088000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 232521,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 132000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": -70669,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 15856000,
    "stockissuedduringperiodvaluenewissues": 6021000,
    "stockissuedduringperiodsharesnewissues": "null",
    "othercomprehensiveincomelossfinancialliabilityfairvalueoptionbeforetaxafterreclassificationadjustmentattributabletoparent": 20000,
    "profitloss": 14192000,
    "depreciationdepletionandamortization": 9436000,
    "noncashleaseexpense": -59000,
    "deferredincometaxesandtaxcredits": -1000,
    "provisionfordoubtfulaccounts": 1877000,
    "inventoryreserveforobsolescence": 904000,
    "employeebenefitsandsharebasedcompensation": 15856000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": -126277000,
    "changeinfairvalueofcontingentstockconsideration": 186000,
    "increasedecreaseinotheroperatingcapitalnet": 37000,
    "increasedecreaseinaccountsreceivable": 3584000,
    "increasedecreaseininventories": 16891000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -49000,
    "increasedecreaseinaccountspayable": -2948000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 4710000,
    "increasedecreaseinrightofuseassetsandleaseliabilities": 263000,
    "increasedecreaseindeferredrevenue": 425000,
    "netcashprovidedbyusedinoperatingactivities": -137876000,
    "paymentstoacquirepropertyplantandequipment": 5236000,
    "netcashprovidedbyusedininvestingactivities": -5236000,
    "proceedsfromwarrantexercises": 46491000,
    "proceedsfromshorttermdebt": 39200000,
    "proceedsfromthesaleofcommonstockinatmoffering": 6519000,
    "paymentsofatthemarketofferingcostsandcommissions": 498000,
    "proceedsfromissuanceofprivateplacement": 30000000,
    "proceedsfromstockoptionsexercised": 862000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 132000,
    "paymentsofdebtissuancecosts": 2604000,
    "netcashprovidedbyusedinfinancingactivities": 119838000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -23274000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 28802000,
    "capitalexpendituresincurredbutnotyetpaid": 683000,
    "conversionofstockamountissued1": 4099000,
    "reclassificationofoptionliabilitiestoequity": 441000,
    "entityincorporationdateofincorporation": "August 24, 2018",
    "numberofclinicaltrials": 3,
    "areaofbuilding": 147215,
    "unrestrictedcashandcashequivalents": 8600000,
    "marketingandadvertisingexpense": 163000,
    "minimumpercentageofrecognizedtaxbenefitlikelihoodofbeingrealizeduponultimatesettlementwithtaxauthority": 0.5,
    "numberofbusinesssegments": 3,
    "instrumentspecificcreditriskincome": 20000,
    "accumulatedothercomprehensiveincometootherincomeuponshorttermdebtconversion": 11000,
    "concentrationriskpercentage1": 0.11,
    "allowancefordoubtfulaccountsreceivable": 1762000,
    "operatingleaseliability": 27985000,
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2023",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no",
    "contractedstorageperiods": 25,
    "paymentplansforcustomertopayovertimeperiod": 24,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "shorter of the estimated useful life or the lease term",
    "incomeloss": 14192000,
    "incrementalcommonsharesattributabletosharebasedpaymentarrangements": "null",
    "weightedaveragenumberofsharesrestrictedstock": 336969,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "commonstockconversionbasis": "At the Effective Time, by virtue of the First Merger and without any action on the part of GX, First Merger Sub, Legacy Celularity or the holders of any of the following securities:",
    "classofwarrantorrightreasonforissuingtononemployees": "In addition, GX had previously issued public warrants and private placement warrants (collectively, the “GX Warrants”) as part of the Units in its IPO in May 2019",
    "fairvalueofwarrants": 1402000,
    "shareprice": 7.53,
    "cashandcashequivalentsfairvaluedisclosure": 12174000,
    "convertiblenotereceivable": 2514000,
    "assetsfairvaluedisclosure": 14688000,
    "contingentstockconsideration": 186000,
    "warrantliabilityprivateinvestmentinpublicequitywarrants": 1402000,
    "warrantliabilitysponsorwarrants": 1190000,
    "warrantliabilitypublicwarrants": 1006000,
    "liabilitiesfairvaluedisclosure": 147332000,
    "contingentconsiderationobligation": 186000,
    "liabilitiesfairvalueadjustment": -126277000,
    "fairvaluenetassetsliability": 3598000,
    "privateinvestmentinpublicequitywarrantissuance": 19745000,
    "gainlossrecognizedinearningsfromchangeinfairvalues": 42109000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 6.77,
    "warrantsandrightsoutstandingmeasurementinput": 81.2,
    "warrantsandrightsoutstandingterm": 4.4,
    "percentageofexerciseprice": 0.8,
    "classofwarrantexercisepricedescription": "(i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon a consummation of a change of control or the closing of a strategic transaction or (ii) the price at which ",
    "facevalueofnotesreceivable": 4000000,
    "percentageofcouponrate": 0.17,
    "valuationmodelthatrelatetosanuwavecommonstock": 0.02,
    "valuationinputforconvertiblepromissorynoteterm": 3.45,
    "valuationinputforconvertiblepromissorynote": 4.73,
    "contingentstockconsiderationobligation": 186000,
    "valuationinputforshorttermdebtshareprice": 1.29,
    "valuationinputforshorttermdebtcreditspread": 0.1371,
    "valuationinputforshorttermdebtterm": 0.71,
    "valuationinputforshorttermdebt": 0.45,
    "valuationinputforshorttermdebtdiscountyield": 0.18460000000000001,
    "inventoryrawmaterialscurrentandnoncurrent": 7719000,
    "inventoryworkinprogresscurrentandnoncurrent": 12381000,
    "inventoryfinishedgoodscurrentandnoncurrent": 9256000,
    "inventorygrosscurrentandnoncurrent": 29356000,
    "inventoryreservecurrentandnoncurrent": 1099000,
    "inventorynetcurrentandnoncurrent": 28257000,
    "prepaidclinicalexpense": 5836000,
    "prepaidinsurance": 377000,
    "otherprepaidexpensecurrent": 1049000,
    "propertyplantandequipmentgross": 95986000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 20331000,
    "depreciation": 7243000,
    "finitelivedintangibleassetsgross": 23993000,
    "finitelivedintangibleassetsaccumulatedamortization": 11499000,
    "finitelivedintangibleassetsnet": 12494000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 108500000,
    "finitelivedintangibleassetusefullife": 6,
    "indefinitelivedintangibleassetsamortizationmethod": "indefinite",
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 2193000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1753000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1493000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1356000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1258000,
    "accruedclinicaltrialexpense": 2659000,
    "accruedprofessionalfeescurrent": 880000,
    "accruedresearchanddevelopmentsoftware": 7333000,
    "employeerelatedliabilitiescurrent": 2576000,
    "accrualsforconstructioninprogress": 322000,
    "otheraccruedliabilitiescurrent": 2632000,
    "accruedliabilitiescurrent": 16402000,
    "debtinstrumentfairvalue": 37603000,
    "operatingleaseweightedaverageremainingleaseterm1": 23.3,
    "operatingleaseweightedaveragediscountratepercent": 0.1112,
    "operatingleasesrentexpense": 3803000,
    "operatingleasepayments": 2834000,
    "operatingleasecost": 3038000,
    "variableleasecost": 1598000,
    "leasecost": 4636000,
    "shorttermleasecost": 126000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2895000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2969000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3042000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 3116000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 3190000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 70341000,
    "lesseeoperatingleaseliabilitypaymentsdue": 85553000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 57568000,
    "costsandexpensesrelatedparty": 8000000,
    "estimatedfairvalueofsharesissuedunderlegalsettlementagreement": 5333000,
    "commonstockvotingrights": "common stock are entitled to one vote per share",
    "percentageofsharesrequiredforvoting": 0.5,
    "preferredstockvotingrights": "Preferred Stock were entitled to vote",
    "numberofsharesrequiredtobeoutstandingforvoting": "null",
    "proceedsfromissuanceinitialpublicoffering": 50000000,
    "conversionpricepershareofcommonstock": 9.41,
    "preferredstockdividendratepercentage": 0.06,
    "preferredstockdividendpaymentterms": "The holders of Preferred Stock were entitled to receive noncumulative dividends when, as and if declared by the board of directors. Dividends accrued on the Preferred Stock at a rate of 6% of the Original Issue Price per year; however, such dividends were only payable when, as and if declared by the board of directors. Holders of the Preferred Stock were to be paid dividends prior and in preference to any dividends on common stock. As of the Closing Date, no cash dividends were declared or paid.",
    "maximumpercentageofsalescommissionfromgrosssalesproceeds": 0.03,
    "grossproceedsfromissuanceofcommonstock": 6519000,
    "proceedsfromissuanceofcommonstock": 6021000,
    "saleofstockpricepershare": 2.45,
    "warrantspersharepercentage": 0.8,
    "descriptionofexercisableterms": "The Public Warrants became exercisable on August 15, 2021, which is the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to GX’s initial public offering.",
    "descriptionofwarrantcallprovision": "at any time while the Public Warrants are exercisable,",
    "classofwarrantorrightoutstanding": "null",
    "warrantsandrightsoutstandingmaturitydate": "May 20, 2027",
    "descriptionofexercisepriceandnumberofsharesofcommonstock": "The exercise price is the lessor of $6.77 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesissuedforfutureissuanceautomaticincreaseperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "two-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "allocatedsharebasedcompensationexpense": 15856000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 7997000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.029500000000000002,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 13367000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.799,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "5 year ",
    "reversedstockbasedcompensationexpenses": 1681000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 648279,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 7851000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 7851000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 7851000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 232521,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 311041,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 7.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 7.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.46,
    "contractwithcustomerliability": 4492000,
    "contractwithcustomerliabilityincreasedecreaseforcontractfrombusinesscombinationanddeferredrevenue": 5004000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 4579000,
    "licenseagreementdescription": "(i) its affiliates without the consent of the Company and (ii) any third party for the sole purpose of providing services directly to Sanuwave upon prior written consent by the Company. ",
    "definedcontributionplanemployerdiscretionarycontributionamount": 1159000,
    "currentstateandlocaltaxexpensebenefit": 13000,
    "currentincometaxexpensebenefit": 13000,
    "deferredfederalincometaxexpensebenefit": 1000,
    "deferredstateandlocalincometaxexpensebenefit": -1000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.389,
    "effectiveincometaxratereconciliationinterestaccretionexpense": -1.869,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 2.6910000000000003,
    "effectiveincometaxratereconciliationmarktomarketwarrant": -0.585,
    "effectiveincometaxratereconciliationdeferredtrueup": 0.002,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.08199999999999999,
    "effectiveincometaxratereconciliationnondeductibleexpenseimpairmentlosses": 0.053,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.031000000000000003,
    "deferredtaxassetsoperatinglosscarryforwards": 102723000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 5674000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 14321000,
    "deferredtaxassetsstartupcosts": 588000,
    "deferredtaxassetsgoodwillandintangibleassets": 3905000,
    "deferredtaxassetsdeferredincome": 1135000,
    "deferredtaxassetsunicap": 6000,
    "deferredtaxassetsimputedinterestoncontingentpayments": 5654000,
    "deferredtaxassetslegalfeecapitalizationandamortization": 1342000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 19318000,
    "deferredtaxassetsother": 3121000,
    "deferredtaxassetsgross": 157787000,
    "deferredtaxliabilitiesinprocessresearchanddevelopment": 27271000,
    "deferredincometaxliabilities": 27271000,
    "deferredtaxassetsvaluationallowance": 130525000,
    "deferredtaxliabilities": 9000,
    "unrecognizedtaxbenefits": 1028000,
    "unrecognizedtaxbenefitsdecreasesresultingfromcurrentperiodtaxpositions": 242000,
    "operatinglosscarryforwards": 102723000,
    "operatinglosscarryforwardsexpirationyear": 2040,
    "taxcreditcarryforwardamount": 5674000,
    "taxcreditcarryforwardsexpirationyear": 2032,
    "grossprofit": -1690000,
    "directoperatingcosts": 144198000,
    "segmentcontribution": -145888000,
    "indirectexpenses": -120288000,
    "adjustmentforamortization": 2193000,
    "othernonoperatingincomeexpense": -120288000,
    "paymentstorelatedparty": 80000,
    "relatedpartytransactionamountsoftransaction": 1821000,
    "relatedpartybasesalary": 216000,
    "relatedpartytransactiontermsandmannerofsettlement": "Effective August 31, 2022, Dr. Pecora resigned as the Company’s President, and subsequently entered into a consulting agreement with the Company dated September 21, 2022, to receive a $10 monthly fee for an initial six-month term and will be automatically renewed for one additional six-month term if either party does not provide notice of non-renewal."
  },
  {
    "date": "2021-12-30",
    "symbol": "CELUW",
    "period": "FY",
    "entityregistrantname": "Celularity Inc.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1752828,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated filer",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38914",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "83-1702591",
    "entityaddressaddressline1": "170 Park Ave",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": "(908)",
    "localphonenumber": "768-2170",
    "security12btitle": "Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share",
    "tradingsymbol": "CELUW",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Parsippany, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 37240000,
    "accountsandotherreceivablesnetcurrent": 2745000,
    "promissorynotesreceivable": 2488000,
    "inventorynet": 9549000,
    "prepaidexpensecurrent": 7076000,
    "otherassetscurrent": 2000,
    "assetscurrent": 59100000,
    "propertyplantandequipmentnet": 90625000,
    "goodwill": 7347000,
    "intangibleassetsnetexcludinggoodwill": 123187000,
    "restrictedcashnoncurrent": 14722000,
    "inventorynoncurrent": 2721000,
    "otherassetsnoncurrent": 355000,
    "assets": 414128000,
    "accountspayablecurrent": 9317000,
    "accruedliabilitiesandotherliabilities": 11661000,
    "financingobligationscurrent": 3051000,
    "contractwithcustomerliabilitycurrent": 2196000,
    "liabilitiescurrent": 26225000,
    "contractwithcustomerliabilitynoncurrent": 1871000,
    "businesscombinationcontingentconsiderationliability": 232222000,
    "financingobligationsnoncurrent": 28085000,
    "warrantliability": 25962000,
    "deferredincometaxliabilitiesnet": 10000,
    "otherliabilitiesnoncurrent": 335000,
    "liabilities": 59202000,
    "commonstockvalue": 12000,
    "additionalpaidincapital": 763087000,
    "retainedearningsaccumulateddeficit": -663681000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 99418000,
    "liabilitiesandstockholdersequity": 414128000,
    "allowancefordoubtfulaccountsreceivablecurrent": 283000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 15813000,
    "costofrevenue": 2476000,
    "researchanddevelopmentexpense": 88353000,
    "sellinggeneralandadministrativeexpense": 71341000,
    "changeinfairvalueofcontingentconsiderationliability": -41145000,
    "amortizationofintangibleassets": 2192000,
    "operatingincomecostsandexpenses": 130394000,
    "operatingincomeloss": -109059000,
    "othernonoperatingincome": 332000,
    "othernonoperatingexpense": 3171000,
    "incomeexpenserelatedtowarrantliabilities": -13482000,
    "othernonoperatingincomeexpenses": -1682000,
    "nonoperatingincomeexpense": 8961000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -100098000,
    "incometaxexpensebenefit": 20000,
    "netincomeloss": -100118000,
    "earningspersharebasicanddiluted": -1.49,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "stockholdersequity": 99418000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 441000,
    "stockissuedduringperiodsharesstockoptionsexercised": 131256,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 40010000,
    "recapitalizationnetofredemptionsequityissuancecostsandmergercostsadditionalpaidincapital": 485598000,
    "recapitalizationnetofredemptionsequityissuancecostsandmergercostsredeemableconvertiblepreferredstockshares": "null",
    "recapitalizationnetofredemptionsequityissuancecostsandmergercostsredeemableconvertiblepreferredstockvalue": -75000000,
    "recapitalizationnetofredemptionsequityissuancecostsandmergercostsshares": 90834,
    "stockissuedduringperiodvaluenewissues": 5333000,
    "stockissuedduringperiodsharesnewissues": 743771,
    "reclassifiedfromwarrantliabilitytoadditionalpaidincapital": 96398000,
    "profitloss": -100118000,
    "depreciationdepletionandamortization": 8817000,
    "deferredincometaxesandtaxcredits": -1353000,
    "provisionfordoubtfulaccounts": 298000,
    "employeebenefitsandsharebasedcompensation": 40010000,
    "fairvalueadjustmentofwarrants": 33240000,
    "issuanceofstockandwarrantsforservicesorclaims": 5333000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": -41145000,
    "increasedecreaseinotheroperatingcapitalnet": -2627000,
    "increasedecreaseinaccountsreceivable": 1909000,
    "increasedecreaseininventories": 6422000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -3068000,
    "saleofnetoperatinglossesandresearchanddevelopmenttaxcredits": 1356000,
    "increasedecreaseinaccountspayable": 3007000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -1801000,
    "increasedecreaseindeferredrevenue": -8382000,
    "netcashprovidedbyusedinoperatingactivities": -110096000,
    "paymentstoacquirepropertyplantandequipment": 6203000,
    "proceedsfrompromissorynote": 300000,
    "netcashprovidedbyusedininvestingactivities": -5903000,
    "proceedsfromrelatedpartydebt": 5000000,
    "repaymentsofrelatedpartydebt": 5000000,
    "cashreceivedonrecapitalization": 5386000,
    "proceedsfrominvestment": 20000000,
    "proceedsfromissuanceofprivateplacement": 83400000,
    "proceedsfromstockoptionsexercised": 638000,
    "paymentsofdebtissuancecosts": 10862000,
    "netcashprovidedbyusedinfinancingactivities": 98562000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -17437000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 52076000,
    "interestpaidnet": 146000,
    "capitalexpendituresincurredbutnotyetpaid": 970000,
    "recapitalizationfrommerger": 550113000,
    "cancellationoftreasurystock": 256000,
    "noncashassetsacquiredfrommerger": 163000,
    "warrantliabilityassumedfrommerger": 59202000,
    "issuanceofcommonstockaspaymentforrelatedcosts": 10795000,
    "reclassificationofwarrantliabilitiestoequity": 96398000,
    "reclassofofferingcostspaidinprioryear": 153000,
    "entityincorporationdateofincorporation": "August 24, 2018",
    "numberofclinicaltrials": 3,
    "areaofbuilding": 150000,
    "substantialdoubtaboutgoingconcernwithinoneyear": "true",
    "numberofoperatingsegments": 1,
    "equipmentevaluationperiod": 90,
    "marketingandadvertisingexpense": 252000,
    "minimumpercentageofrecognizedtaxbenefitlikelihoodofbeingrealizeduponultimatesettlementwithtaxauthority": 0.5,
    "numberofbusinesssegments": 3,
    "concentrationriskpercentage1": 0.47000000000000003,
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2022",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "shorter of the estimated useful life and the lease term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "classofwarrantorrightreasonforissuingtononemployees": "In addition, GX had previously issued public warrants and private placement warrants (collectively, the “GX Warrants”) as part of the Units in its initial public offering in May 2019",
    "fairvalueofwarrants": 13600000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": "null",
    "shareprice": 7.53,
    "licensearrangementterm": "P5Y",
    "proceedsfromdivestitureofbusinesses": 9505000,
    "debtinstrumentmaturitydate": "June 8, 2022",
    "disposalgroupincludingdiscontinuedoperationconsideration": 15019000,
    "disposalgroupincludingdiscontinuedoperationdiscountrateofdiscountedcashflow": 0.11,
    "disposalgroupincludingdiscontinuedoperationtaxrateofdiscountedcashflow": 0.26,
    "disposalgroupincludingdiscontinuedoperationlongtermgrowthrateofdiscountedcashflow": 0.02,
    "disposalgroupnotdiscontinuedoperationgainlossondisposal": -4434000,
    "disposalgroupincludingdiscontinuedoperationprofessionalfees": 40000,
    "cashandcashequivalentsfairvaluedisclosure": 36700000,
    "convertiblenotereceivable": 2488000,
    "assetsfairvaluedisclosure": 39188000,
    "warrantliabilitysponsorwarrants": 13600000,
    "warrantliabilitypublicwarrants": 12362000,
    "liabilitiesfairvaluedisclosure": 258184000,
    "fairvaluenetassetsliability": 25962000,
    "contingentconsiderationobligation": 232222000,
    "liabilitiesfairvalueadjustment": -41145000,
    "gainlossrecognizedinearningsfromchangeinfairvalues": -13482000,
    "warrantliabilityassumedatclosingdate": 24438000,
    "reclassificationoflegacycelularitywarrantstoequity": -96398000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 7.53,
    "warrantsandrightsoutstandingmeasurementinput": 63,
    "warrantsandrightsoutstandingterm": "P4Y6M",
    "percentageofexerciseprice": 0.8,
    "facevalueofnotesreceivable": 4000000,
    "percentageofcouponrate": 0.17,
    "valuationmodelthatrelatetosanuwavecommonstock": 0.17,
    "valuationinputforconvertiblepromissorynoteterm": "P3Y2M8D",
    "valuationinputforconvertiblepromissorynote": 0.29,
    "inventoryrawmaterialscurrentandnoncurrent": 2359000,
    "inventoryworkinprogresscurrentandnoncurrent": 5902000,
    "inventoryfinishedgoodscurrentandnoncurrent": 4057000,
    "inventorygrosscurrentandnoncurrent": 12318000,
    "inventoryreservecurrentandnoncurrent": 48000,
    "inventorynetcurrentandnoncurrent": 12270000,
    "prepaidclinicalexpense": 3269000,
    "prepaidinsurance": 1399000,
    "otherprepaidexpensecurrent": 2408000,
    "propertyplantandequipmentgross": 105404000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 14779000,
    "saleleasebacktransactionhistoricalcost": 70959000,
    "saleleasebacktransactionaccumulateddepreciation": 5971000,
    "depreciation": 6625000,
    "finitelivedintangibleassetsgross": 23993000,
    "finitelivedintangibleassetsaccumulatedamortization": 9306000,
    "finitelivedintangibleassetsnet": 14687000,
    "acquiredproductrights": 108500000,
    "finitelivedintangibleassetusefullife": 6,
    "indefinitelivedintangibleassetsamortizationmethod": "Indefinite",
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 2193000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 2193000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1784000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1493000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1356000,
    "accruedclinicaltrialexpense": 1861000,
    "accruedprofessionalfeescurrent": 1653000,
    "employeerelatedliabilitiescurrent": 3824000,
    "deferredrentcreditcurrent": 2000,
    "otheraccruedliabilitiescurrent": 4321000,
    "accruedliabilitiescurrent": 11661000,
    "repaymentsofshorttermdebtincludingaccruedinterestandexitfee": 5146000,
    "leaseandrentalexpense": 668000,
    "costsandexpensesrelatedparty": 5333000,
    "estimatedfairvalueofsharesissuedunderlegalsettlementagreement": 5333000,
    "operatingleasesfutureminimumpaymentsduecurrent": 2861000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 2895000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 2969000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 3042000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 3116000,
    "operatingleasesfutureminimumpaymentsduethereafter": 73531000,
    "operatingleasesfutureminimumpaymentsdue": 88414000,
    "commonstockvotingrights": "common stock are entitled to one vote per share",
    "percentageofsharesrequiredforvoting": 0.5,
    "preferredstockvotingrights": "Preferred Stock were entitled to vote",
    "numberofsharesrequiredtobeoutstandingforvoting": "null",
    "proceedsfromissuanceinitialpublicoffering": 50000000,
    "conversionpricepershareofcommonstock": 9.41,
    "preferredstockdividendratepercentage": 0.06,
    "preferredstockdividendpaymentterms": "The holders of Preferred Stock were entitled to receive noncumulative dividends when, as and if declared by the board of directors. Dividends accrued on the Preferred Stock at a rate of 6% of the Original Issue Price per year; however, such dividends were only payable when, as and if declared by the board of directors. Holders of the Preferred Stock were to be paid dividends prior and in preference to any dividends on common stock. As of the Closing Date, no cash dividends were declared or paid.",
    "warrantspersharepercentage": 0.8,
    "descriptionofexercisableterms": "The Public Warrants became exercisable on August 15, 2021, which is the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to GX’s initial public offering.",
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "August 15, 2021",
    "warrantsexercisableperiodaftercompletionofbusinesscombination": 30,
    "warrantsexercisableperiodfromeffectivedateofinitialpublicoffering": 12,
    "warrantexpirationterm": "five years",
    "publicwarrantscallprice": 0.01,
    "minimumwrittennoticeperiodforredemption": 30,
    "descriptionofwarrantcallprovision": " •at any time while the Public Warrants are exercisable,",
    "aggregatenumberofwarrantsissuedasrepaymentforworkingcapitalloans": "null",
    "classofwarrantorrightoutstanding": "null",
    "warrantsandrightsoutstandingmaturitydate": "July 16, 2026",
    "descriptionofexercisepriceandnumberofsharesofcommonstock": "The exercise price is the lessor of $6.77 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesissuedforfutureissuanceautomaticincreaseperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.13,
    "allocatedsharebasedcompensationexpense": 40010000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2959000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 6499000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.92,
    "expenserelatedtoperformanceawards": 31000,
    "awardmodificationexpense": 121000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "vest in up to five equal installments in respect of achieving certain share price targets between the third and fourth anniversary of the effective date",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.804,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.5,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3296000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P4Y7M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 56525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 56525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 51898000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 474700,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 488600,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 13900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 7.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 7.2,
    "contractwithcustomerliability": 4067000,
    "contractwithcustomerliabilityincreasedecreaseforcontractfrombusinesscombinationanddeferredrevenue": 4928000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 13310000,
    "contractwithcustomerliabilityrevenuerecognized": 2196000,
    "contractedstorageperiods": 25,
    "paymentplansforcustomertopayovertimeperiod": 24,
    "revenuepracticalexpedientfinancingcomponent": "true",
    "deferredrevenue": 4067000,
    "supplyanddistributionagreementforecastdescription": "The forecast may not deviate to less than 70% for the immediate following quarter, 50% two quarters out, 40% three quarters out, and 25% for full quarters from the original forecasted amount for that specific quarter set forth in the respective agreed upon binding forecast. Upon agreement, Evolution shall submit to the Company a purchase order to purchase products for the minimum binding forecasted quantities.",
    "definedcontributionplanemployerdiscretionarycontributionamount": 989000,
    "currentstateandlocaltaxexpensebenefit": 17000,
    "currentincometaxexpensebenefit": 17000,
    "deferredfederalincometaxexpensebenefit": 1000,
    "deferredstateandlocalincometaxexpensebenefit": 2000,
    "deferredincometaxexpensebenefit": 3000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.098,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.015,
    "effectiveincometaxratereconciliationinterestaccretionexpense": 0.086,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.461,
    "effectiveincometaxratereconciliationmarktomarketwarrant": 0.027999999999999997,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.024,
    "deferredtaxassetsoperatinglosscarryforwards": 88327000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 7672000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 11748000,
    "deferredtaxassetsstartupcosts": 697000,
    "deferredtaxassetsgoodwillandintangibleassets": 4471000,
    "deferredtaxassetsdeferredincome": 1103000,
    "deferredtaxassetsunicap": 6000,
    "deferredtaxassetsimputedinterestoncontingentpayments": 4410000,
    "deferredtaxassetslegalfeecapitalizationandamortization": 1550000,
    "deferredtaxassetsother": 1535000,
    "deferredtaxassetsgross": 121519000,
    "deferredtaxliabilitiesinprocessresearchanddevelopment": 29232000,
    "deferredincometaxliabilities": 29232000,
    "deferredtaxassetsvaluationallowance": 92297000,
    "deferredtaxliabilities": 10000,
    "unrecognizedtaxbenefits": 1270000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 242000,
    "operatinglosscarryforwards": 88221000,
    "operatinglosscarryforwardsexpirationyear": 2040,
    "taxcreditcarryforwardamount": 7856000,
    "taxcreditcarryforwardsexpirationyear": 2032,
    "netoperatinglossesandunusedresearchanddevelopmenttaxcreditssold": 1356000,
    "grossprofit": 11682000,
    "directoperatingcosts": 159693000,
    "segmentcontribution": -148011000,
    "indirectexpenses": -38953000,
    "incomelossfromcontinuingoperations": -109058000,
    "adjustmentforamortization": 2192000,
    "othernonoperatingincomeexpense": -38953000,
    "paymentstorelatedparty": 390000,
    "relatedpartytransactionamountsoftransaction": 104000,
    "numberofsharesholding": "null",
    "relatedpartyfulltimebasesalary": 210000
  },
  {
    "date": "2020-12-30",
    "symbol": "CELUW",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 314696,
    "prepaidtaxes": 10381,
    "otherprepaidexpensecurrent": 34212,
    "assetscurrent": 359289,
    "assetsheldintrustnoncurrent": 291797144,
    "assets": 292156433,
    "accountspayableandaccruedliabilitiescurrent": 3409872,
    "liabilitiescurrent": 3409872,
    "deferredincometaxliabilitiesnet": 602,
    "deferredunderwritingfees1": 10812500,
    "liabilities": 14222974,
    "redeemablenoncontrollinginterestequitycarryingamount": 272933454,
    "commonstockvalue": 719,
    "additionalpaidincapital": 5117524,
    "retainedearningsaccumulateddeficit": -118424,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 5000005,
    "liabilitiesandstockholdersequity": 292156433,
    "temporaryequityredemptionpricepershare": 26894145,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 1000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 10000000,
    "commonstocksharesissued": 7187500,
    "commonstocksharesoutstanding": 7187500,
    "operatingcostsandexpenses": 4219960,
    "operatingincomeloss": -4219960,
    "investmentincomeinterest": 1779071,
    "unrealizedgainlossonsecurities": 2236,
    "nonoperatingincomeexpense": 1781307,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -2438653,
    "incometaxexpensebenefit": 191644,
    "netincomeloss": -2630297,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 8678704,
    "earningspersharebasicanddiluted": -0.45,
    "aggregatesharessubjecttopossibleredemption": 26894145,
    "temporaryequityaccretiontoredemptionvalueadjustment": 1299844,
    "stockholdersequity": 5000005,
    "sharesoutstanding": 7187500,
    "changeinvalueofclassacommonstocksubjecttopossibleredemption": 2630301,
    "changeinvalueofclassacommonstocksubjecttopossibleredemptioninshares": 389338,
    "deferredincometaxexpensebenefit": 2255,
    "increasedecreaseinprepaidtaxes": 10381,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -57938,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3199661,
    "increasedecreaseinaccruedincometaxespayable": -18883,
    "netcashprovidedbyusedinoperatingactivities": -1181014,
    "paymentstoinvestindecommissioningfund": 137500,
    "proceedsfromcashwithdrawnfromtrustaccounttopayfranchiseandincometaxes": 716203,
    "netcashprovidedbyusedininvestingactivities": 578703,
    "cashandcashequivalentsperiodincreasedecrease": -602311,
    "incometaxespaid": 218653,
    "changeinvalueofcommonstocksubjecttopossibleredemption": -2630301,
    "netincomelossavailabletocommonstockholdersbasic": -3930141,
    "unrealizedgainlossonmarketablesecurities": -602,
    "totaldeferredtaxliabilityassets": -602,
    "deferredtaxliabilityassetnetofallowance": -602,
    "currentincometaxexpensebenefit": 189389,
    "deferredfederalincometaxexpensebenefit": 2255,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationdispositionofbusiness": -0.289,
    "effectiveincometaxratecontinuingoperations": -0.079,
    "investmentsfairvaluedisclosure": 291797144,
    "saleofstocknumberofsharesissuedintransaction": 3750000,
    "saleofstockpricepershare": 11.5,
    "proceedsfromissuanceinitialpublicoffering": 7000000,
    "deferredofferingcosts": 16473117,
    "expenserelatedtodistributionorservicingandunderwritingfees": 5000000,
    "deferredunderwritingfees": 10812500,
    "expenserelatedtodistributionorservicingandunderwritingfees1": 660617,
    "percentageoftrustaccountrequiredforbusinesscombination": 0.8,
    "businessacquisitionpercentageofvotinginterestsacquired": 0.5,
    "amountofthresholdtangibleassets": 5000001,
    "publicutilitiesdescriptionofregulatoryscope": "15% or more",
    "operatingbankaccounts": 314696,
    "assetsheldintrust": 291797144,
    "workingcapitalexcludesfranchiseandincometaxespayable": 3020914,
    "amountondepositintrustaccount": 4297000,
    "interestexpensetrustpreferredsecurities": 1367203,
    "proceedsfromsaleoftrustassetstopayexpenses": 716203,
    "trustaccountreductionoftaxliability": 137500,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 21375000,
    "cashfdicinsuredamount": 250000,
    "saleofstockdescriptionoftransaction": "Each Unit consists of one share of the Company&#x2019;s Class A common stock, $0.0001 par value, and one-half of one redeemable warrant (&#x201c;Public Warrant&#x201d;). Each Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 7).",
    "sharesissued": 937500,
    "debtconversionoriginaldebtamount1": 1500000,
    "debtinstrumentconvertibleconversionprice1": 10,
    "incurredservicefeespaid": 120000,
    "registrationpaymentarrangementterm": "The holders of 25% of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination.",
    "deferredfee": 10812500,
    "advisoryandconsultingagreements": "(i) $3 million (the &#x201c;Minimum Fee&#x201d;) and (ii) 3% of the gross proceeds of the total Securities sold in the Transaction and 3% of the gross proceeds of the total Securities sold in the Transaction.",
    "transactionfee": 5000000,
    "duediligence": 75000,
    "commonstockvotingrights": "common stock are entitled to one vote for each share.",
    "temporaryequitysharesissued": 26894145,
    "temporaryequitysharesoutstanding": 27283483,
    "commonstockconversionfeatures": "The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like.",
    "descriptionofexercisableterms": "Warrants &#x2014; The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to the Initial Public Offering.",
    "warrantexpirationrerm": "P5Y",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.01,
    "descriptionofwarrantredemption": "&#x25cf; at any time while the Public Warrants are exercisable, &#x25cf; upon not less than 30 days&#x2019; prior written notice of redemption to each Public Warrant holder, &#x25cf; if, and only if, there is a current registration statement in effect with respect to the issuance of the common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing",
    "entityregistrantname": "GX Acquisition Corp.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1752828,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-38914",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes"
  },
  {
    "date": "2019-12-30",
    "symbol": "CELUW",
    "period": "FY",
    "entityregistrantname": "GX Acquisition Corp.",
    "entitycentralindexkey": 1752828,
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "true",
    "entityfilenumber": "001-38914",
    "entityincorporationstatecountrycode": "DE",
    "cashandcashequivalentsatcarryingvalue": 917007,
    "prepaidexpensecurrent": 92150,
    "assetscurrent": 1009157,
    "deferredtaxasset": 1653,
    "assetsheldintrustnoncurrent": 290594540,
    "assets": 291605350,
    "accountspayableandaccruedliabilitiescurrent": 210211,
    "taxespayablecurrent": 18883,
    "liabilitiescurrent": 229094,
    "deferredunderwritingfees1": 10812500,
    "liabilities": 11041594,
    "redeemablenoncontrollinginterestequitycarryingamount": 275563755,
    "commonstockvalue": 719,
    "additionalpaidincapital": 2487262,
    "retainedearningsaccumulateddeficit": 2511873,
    "stockholdersequity": 2511873,
    "liabilitiesandstockholdersequity": 291605350,
    "temporaryequitysharesredemption": 27283483,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 10000000,
    "commonstocksharesissued": 7187500,
    "commonstocksharesoutstanding": 7187500,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 1000000,
    "operatingcostsandexpenses": 564339,
    "operatingincomeloss": -564339,
    "investmentincomeinterest": 3753411,
    "unrealizedgainlossonsecurities": -7871,
    "nonoperatingincomeexpense": 3745540,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 3181201,
    "incometaxexpensebenefit": 668230,
    "netincomeloss": 2512971,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 8015444,
    "earningspersharebasicanddiluted": -0.03,
    "temporaryequityaccretiontoredemptionvalueadjustment": 2730520,
    "sharesoutstanding": 7187500,
    "saleofnetofunderwritingdiscountsandofferingexpenses": 271024008,
    "saleofnetofunderwritingdiscountsandofferingexpensesinshares": 28750000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 7000000,
    "stockissuedduringperiodvaluesharebasedcompensation": 144,
    "stockissuedduringperiodsharessharebasedcompensation": -1437500,
    "stockredeemedorcalledduringperiodvalue": -275561027,
    "stockredeemedorcalledduringperiodshares": 27283483,
    "deferredincometaxexpensebenefit": -1653,
    "increasedecreaseinprepaidexpense": 92150,
    "increasedecreaseinaccountspayableandaccruedliabilities": 209656,
    "increasedecreaseinaccruedincometaxespayable": 18883,
    "netcashprovidedbyusedinoperatingactivities": -1097833,
    "paymentstoacquireinvestments": 287500000,
    "proceedsfromsaleoftrustassetstopayexpenses": 651000,
    "netcashprovidedbyusedininvestingactivities": -286849000,
    "proceedsfromsaleofunitsnetofunderwritingdiscountspaid": 282500000,
    "proceedsfromissuanceofprivateplacement": 7000000,
    "proceedsfromrelatedpartydebt": 130000,
    "repaymentsofrelatedpartydebt": 280000,
    "paymentsofstockissuancecosts": 510867,
    "netcashprovidedbyusedinfinancingactivities": 288839133,
    "cashandcashequivalentsperiodincreasedecrease": 892300,
    "incometaxespaid": 651000,
    "initialclassificationofcommonstocksubjecttoredemption": 273048700,
    "changeinvalueofcommonstocksubjecttopossibleredemption": 2515055,
    "deferredunderwritingfeepayable": 10812500,
    "deferredofferingcosts": 16473117,
    "deferredunderwritingfees": 10812500,
    "expenserelatedtodistributionorservicingandunderwritingfees": 5000000,
    "expenserelatedtodistributionorservicingandunderwritingfees1": 660617,
    "workingcapital": 917007,
    "percentageoftrustaccountrequiredforbusinesscombination": 0.8,
    "businessacquisitionpercentageofvotinginterestsacquired": 0.5,
    "amountofthresholdtangibleassets": 5000001,
    "netincomelossavailabletocommonstockholdersbasic": -217549,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 21375000,
    "cashfdicinsuredamount": 250000,
    "paymentforsecretarialadministrativefeesexpense": 80000,
    "debtconversionoriginaldebtamount1": 1500000,
    "debtinstrumentconvertibleconversionprice1": 10,
    "registrationpaymentarrangementterm": "The holders of 25% of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination.",
    "monthlyfeepayable": 90500,
    "deferredfee": 10812500,
    "commonstockvotingrights": "Common stock are entitled to one vote for each share.",
    "warrantexpirationrerm": "P5Y",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.01,
    "descriptionofwarrantredemption": "  ● at any time while the Public Warrants are exercisable,    ● upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,    ● if, and only if, there is a current registration statement in effect with respect to the issuance of the common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing",
    "descriptionofexercisableterms": "(a) 30 days after the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to the Initial Public Offering.",
    "commonstockconversionfeatures": "The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like.",
    "deferredtaxassetsunrealizedlossesontradingsecurities": 1653,
    "deferredtaxassetsgross": 1653,
    "deferredtaxassetsnet": 1653,
    "currentfederaltaxexpensebenefit": -1653,
    "deferredfederalincometaxexpensebenefit": 669883,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratecontinuingoperations": 0.21,
    "investmentsfairvaluedisclosure": 290594540
  }
]